Host control of persistent Epstein–Barr virus infection

Key Points

• Persistent Epstein-Barr virus infection is notably regulated by the host's immune response, showcasing critical interactions.
• Key evidence indicates that effective immune control can significantly reduce viral latency, with implications for treatment.
• Analysis of host interactions explores how immune responses manage viral persistence and influence disease outcomes.
• Highlights the need for understanding immune mechanisms, which may enable targeted therapies against Epstein-Barr virus.